aluates Reports

$ 0.0

Automative

Global Oncology Precision Medicine Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-33A5667

Global Oncology Precision Medicine Market Insights Forecast to 2028

BUY CHAPTERS

Global Oncology Precision Medicine Market Research Report 2024

Code: QYRE-Auto-33A5667

Report

June 2024

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Oncology Precision Medicine Market Size

The global Oncology Precision Medicine market was valued at US$ 35710 million in 2023 and is anticipated to reach US$ 47750 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

Oncology Precision Medicine Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Oncology Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Precision Medicine.

Report Scope

The Oncology Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Precision Medicine Market Report

Report Metric	Details
Report Name	Oncology Precision Medicine Market
Accounted market size in 2023	US$ 35710 million
Forecasted market size in 2030	US$ 47750 million
CAGR	4.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Applied Sciences Precision Diagnostics Digital Health and Information Technology Precision Therapeutics
Segment by Application	Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Cervical Cancer Other Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncology Precision Medicine Market growing?

Ans: The Oncology Precision Medicine Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Oncology Precision Medicine Market size in 2030?

Ans: The Oncology Precision Medicine Market size in 2030 will be US$ 47750 million.

Who are the main players in the Oncology Precision Medicine Market report?

Ans: The main players in the Oncology Precision Medicine Market are Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen

What are the Application segmentation covered in the Oncology Precision Medicine Market report?

Ans: The Applications covered in the Oncology Precision Medicine Market report are Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer

What are the Type segmentation covered in the Oncology Precision Medicine Market report?

Ans: The Types covered in the Oncology Precision Medicine Market report are Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Precision Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Applied Sciences

1.2.3 Precision Diagnostics

1.2.4 Digital Health and Information Technology

1.2.5 Precision Therapeutics

1.3 Market by Application

1.3.1 Global Oncology Precision Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Colorectal Cancer

1.3.5 Prostate Cancer

1.3.6 Cervical Cancer

1.3.7 Other Cancer

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncology Precision Medicine Market Perspective (2019-2030)

2.2 Oncology Precision Medicine Growth Trends by Region

2.2.1 Global Oncology Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oncology Precision Medicine Historic Market Size by Region (2019-2024)

2.2.3 Oncology Precision Medicine Forecasted Market Size by Region (2025-2030)

2.3 Oncology Precision Medicine Market Dynamics

2.3.1 Oncology Precision Medicine Industry Trends

2.3.2 Oncology Precision Medicine Market Drivers

2.3.3 Oncology Precision Medicine Market Challenges

2.3.4 Oncology Precision Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Precision Medicine Players by Revenue

3.1.1 Global Top Oncology Precision Medicine Players by Revenue (2019-2024)

3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oncology Precision Medicine Revenue

3.4 Global Oncology Precision Medicine Market Concentration Ratio

3.4.1 Global Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Precision Medicine Revenue in 2023

3.5 Oncology Precision Medicine Key Players Head office and Area Served

3.6 Key Players Oncology Precision Medicine Product Solution and Service

3.7 Date of Enter into Oncology Precision Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Precision Medicine Breakdown Data by Type

4.1 Global Oncology Precision Medicine Historic Market Size by Type (2019-2024)

4.2 Global Oncology Precision Medicine Forecasted Market Size by Type (2025-2030)

5 Oncology Precision Medicine Breakdown Data by Application

5.1 Global Oncology Precision Medicine Historic Market Size by Application (2019-2024)

5.2 Global Oncology Precision Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oncology Precision Medicine Market Size (2019-2030)

6.2 North America Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Oncology Precision Medicine Market Size by Country (2019-2024)

6.4 North America Oncology Precision Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncology Precision Medicine Market Size (2019-2030)

7.2 Europe Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Oncology Precision Medicine Market Size by Country (2019-2024)

7.4 Europe Oncology Precision Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncology Precision Medicine Market Size (2019-2030)

8.2 Asia-Pacific Oncology Precision Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Oncology Precision Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncology Precision Medicine Market Size (2019-2030)

9.2 Latin America Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Oncology Precision Medicine Market Size by Country (2019-2024)

9.4 Latin America Oncology Precision Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Precision Medicine Market Size (2019-2030)

10.2 Middle East & Africa Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Oncology Precision Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Oncology Precision Medicine Introduction

11.1.4 Abbott Laboratories Revenue in Oncology Precision Medicine Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Detail

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Oncology Precision Medicine Introduction

11.2.4 Agilent Technologies Revenue in Oncology Precision Medicine Business (2019-2024)

11.2.5 Agilent Technologies Recent Development

11.3 Almac

11.3.1 Almac Company Detail

11.3.2 Almac Business Overview

11.3.3 Almac Oncology Precision Medicine Introduction

11.3.4 Almac Revenue in Oncology Precision Medicine Business (2019-2024)

11.3.5 Almac Recent Development

11.4 ANGLE plc

11.4.1 ANGLE plc Company Detail

11.4.2 ANGLE plc Business Overview

11.4.3 ANGLE plc Oncology Precision Medicine Introduction

11.4.4 ANGLE plc Revenue in Oncology Precision Medicine Business (2019-2024)

11.4.5 ANGLE plc Recent Development

11.5 Asuragen

11.5.1 Asuragen Company Detail

11.5.2 Asuragen Business Overview

11.5.3 Asuragen Oncology Precision Medicine Introduction

11.5.4 Asuragen Revenue in Oncology Precision Medicine Business (2019-2024)

11.5.5 Asuragen Recent Development

11.6 BGI Group

11.6.1 BGI Group Company Detail

11.6.2 BGI Group Business Overview

11.6.3 BGI Group Oncology Precision Medicine Introduction

11.6.4 BGI Group Revenue in Oncology Precision Medicine Business (2019-2024)

11.6.5 BGI Group Recent Development

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Detail

11.7.2 Bio-Rad Laboratories Business Overview

11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Introduction

11.7.4 Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2019-2024)

11.7.5 Bio-Rad Laboratories Recent Development

11.8 BioMérieux

11.8.1 BioMérieux Company Detail

11.8.2 BioMérieux Business Overview

11.8.3 BioMérieux Oncology Precision Medicine Introduction

11.8.4 BioMérieux Revenue in Oncology Precision Medicine Business (2019-2024)

11.8.5 BioMérieux Recent Development

11.9 Bristol Myers Squibb

11.9.1 Bristol Myers Squibb Company Detail

11.9.2 Bristol Myers Squibb Business Overview

11.9.3 Bristol Myers Squibb Oncology Precision Medicine Introduction

11.9.4 Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2019-2024)

11.9.5 Bristol Myers Squibb Recent Development

11.10 Roche Holding AG

11.10.1 Roche Holding AG Company Detail

11.10.2 Roche Holding AG Business Overview

11.10.3 Roche Holding AG Oncology Precision Medicine Introduction

11.10.4 Roche Holding AG Revenue in Oncology Precision Medicine Business (2019-2024)

11.10.5 Roche Holding AG Recent Development

11.11 Gilead Sciences

11.11.1 Gilead Sciences Company Detail

11.11.2 Gilead Sciences Business Overview

11.11.3 Gilead Sciences Oncology Precision Medicine Introduction

11.11.4 Gilead Sciences Revenue in Oncology Precision Medicine Business (2019-2024)

11.11.5 Gilead Sciences Recent Development

11.12 Illumina

11.12.1 Illumina Company Detail

11.12.2 Illumina Business Overview

11.12.3 Illumina Oncology Precision Medicine Introduction

11.12.4 Illumina Revenue in Oncology Precision Medicine Business (2019-2024)

11.12.5 Illumina Recent Development

11.13 Konica Minolta

11.13.1 Konica Minolta Company Detail

11.13.2 Konica Minolta Business Overview

11.13.3 Konica Minolta Oncology Precision Medicine Introduction

11.13.4 Konica Minolta Revenue in Oncology Precision Medicine Business (2019-2024)

11.13.5 Konica Minolta Recent Development

11.14 LabCorp

11.14.1 LabCorp Company Detail

11.14.2 LabCorp Business Overview

11.14.3 LabCorp Oncology Precision Medicine Introduction

11.14.4 LabCorp Revenue in Oncology Precision Medicine Business (2019-2024)

11.14.5 LabCorp Recent Development

11.15 MDxHealth

11.15.1 MDxHealth Company Detail

11.15.2 MDxHealth Business Overview

11.15.3 MDxHealth Oncology Precision Medicine Introduction

11.15.4 MDxHealth Revenue in Oncology Precision Medicine Business (2019-2024)

11.15.5 MDxHealth Recent Development

11.16 Myriad Genetics

11.16.1 Myriad Genetics Company Detail

11.16.2 Myriad Genetics Business Overview

11.16.3 Myriad Genetics Oncology Precision Medicine Introduction

11.16.4 Myriad Genetics Revenue in Oncology Precision Medicine Business (2019-2024)

11.16.5 Myriad Genetics Recent Development

11.17 Novartis

11.17.1 Novartis Company Detail

11.17.2 Novartis Business Overview

11.17.3 Novartis Oncology Precision Medicine Introduction

11.17.4 Novartis Revenue in Oncology Precision Medicine Business (2019-2024)

11.17.5 Novartis Recent Development

11.18 OPKO Health

11.18.1 OPKO Health Company Detail

11.18.2 OPKO Health Business Overview

11.18.3 OPKO Health Oncology Precision Medicine Introduction

11.18.4 OPKO Health Revenue in Oncology Precision Medicine Business (2019-2024)

11.18.5 OPKO Health Recent Development

11.19 Pacific Biosciences

11.19.1 Pacific Biosciences Company Detail

11.19.2 Pacific Biosciences Business Overview

11.19.3 Pacific Biosciences Oncology Precision Medicine Introduction

11.19.4 Pacific Biosciences Revenue in Oncology Precision Medicine Business (2019-2024)

11.19.5 Pacific Biosciences Recent Development

11.20 Quest Diagnostics

11.20.1 Quest Diagnostics Company Detail

11.20.2 Quest Diagnostics Business Overview

11.20.3 Quest Diagnostics Oncology Precision Medicine Introduction

11.20.4 Quest Diagnostics Revenue in Oncology Precision Medicine Business (2019-2024)

11.20.5 Quest Diagnostics Recent Development

11.21 Qiagen

11.21.1 Qiagen Company Detail

11.21.2 Qiagen Business Overview

11.21.3 Qiagen Oncology Precision Medicine Introduction

11.21.4 Qiagen Revenue in Oncology Precision Medicine Business (2019-2024)

11.21.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Applied Sciences

Table 3. Key Players of Precision Diagnostics

Table 4. Key Players of Digital Health and Information Technology

Table 5. Key Players of Precision Therapeutics

Table 6. Global Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Oncology Precision Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Oncology Precision Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Oncology Precision Medicine Market Share by Region (2019-2024)

Table 10. Global Oncology Precision Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Oncology Precision Medicine Market Share by Region (2025-2030)

Table 12. Oncology Precision Medicine Market Trends

Table 13. Oncology Precision Medicine Market Drivers

Table 14. Oncology Precision Medicine Market Challenges

Table 15. Oncology Precision Medicine Market Restraints

Table 16. Global Oncology Precision Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Oncology Precision Medicine Market Share by Players (2019-2024)

Table 18. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2023)

Table 19. Ranking of Global Top Oncology Precision Medicine Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Oncology Precision Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Oncology Precision Medicine Product Solution and Service

Table 23. Date of Enter into Oncology Precision Medicine Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Oncology Precision Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Oncology Precision Medicine Revenue Market Share by Type (2019-2024)

Table 27. Global Oncology Precision Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Oncology Precision Medicine Revenue Market Share by Type (2025-2030)

Table 29. Global Oncology Precision Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Oncology Precision Medicine Revenue Market Share by Application (2019-2024)

Table 31. Global Oncology Precision Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Oncology Precision Medicine Revenue Market Share by Application (2025-2030)

Table 33. North America Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Oncology Precision Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Oncology Precision Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Oncology Precision Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 48. Abbott Laboratories Company Detail

Table 49. Abbott Laboratories Business Overview

Table 50. Abbott Laboratories Oncology Precision Medicine Product

Table 51. Abbott Laboratories Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 52. Abbott Laboratories Recent Development

Table 53. Agilent Technologies Company Detail

Table 54. Agilent Technologies Business Overview

Table 55. Agilent Technologies Oncology Precision Medicine Product

Table 56. Agilent Technologies Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 57. Agilent Technologies Recent Development

Table 58. Almac Company Detail

Table 59. Almac Business Overview

Table 60. Almac Oncology Precision Medicine Product

Table 61. Almac Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 62. Almac Recent Development

Table 63. ANGLE plc Company Detail

Table 64. ANGLE plc Business Overview

Table 65. ANGLE plc Oncology Precision Medicine Product

Table 66. ANGLE plc Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 67. ANGLE plc Recent Development

Table 68. Asuragen Company Detail

Table 69. Asuragen Business Overview

Table 70. Asuragen Oncology Precision Medicine Product

Table 71. Asuragen Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 72. Asuragen Recent Development

Table 73. BGI Group Company Detail

Table 74. BGI Group Business Overview

Table 75. BGI Group Oncology Precision Medicine Product

Table 76. BGI Group Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 77. BGI Group Recent Development

Table 78. Bio-Rad Laboratories Company Detail

Table 79. Bio-Rad Laboratories Business Overview

Table 80. Bio-Rad Laboratories Oncology Precision Medicine Product

Table 81. Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 82. Bio-Rad Laboratories Recent Development

Table 83. BioMérieux Company Detail

Table 84. BioMérieux Business Overview

Table 85. BioMérieux Oncology Precision Medicine Product

Table 86. BioMérieux Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 87. BioMérieux Recent Development

Table 88. Bristol Myers Squibb Company Detail

Table 89. Bristol Myers Squibb Business Overview

Table 90. Bristol Myers Squibb Oncology Precision Medicine Product

Table 91. Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 92. Bristol Myers Squibb Recent Development

Table 93. Roche Holding AG Company Detail

Table 94. Roche Holding AG Business Overview

Table 95. Roche Holding AG Oncology Precision Medicine Product

Table 96. Roche Holding AG Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 97. Roche Holding AG Recent Development

Table 98. Gilead Sciences Company Detail

Table 99. Gilead Sciences Business Overview

Table 100. Gilead Sciences Oncology Precision Medicine Product

Table 101. Gilead Sciences Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 102. Gilead Sciences Recent Development

Table 103. Illumina Company Detail

Table 104. Illumina Business Overview

Table 105. Illumina Oncology Precision Medicine Product

Table 106. Illumina Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 107. Illumina Recent Development

Table 108. Konica Minolta Company Detail

Table 109. Konica Minolta Business Overview

Table 110. Konica Minolta Oncology Precision Medicine Product

Table 111. Konica Minolta Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 112. Konica Minolta Recent Development

Table 113. LabCorp Company Detail

Table 114. LabCorp Business Overview

Table 115. LabCorp Oncology Precision Medicine Product

Table 116. LabCorp Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 117. LabCorp Recent Development

Table 118. MDxHealth Company Detail

Table 119. MDxHealth Business Overview

Table 120. MDxHealth Oncology Precision Medicine Product

Table 121. MDxHealth Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 122. MDxHealth Recent Development

Table 123. Myriad Genetics Company Detail

Table 124. Myriad Genetics Business Overview

Table 125. Myriad Genetics Oncology Precision Medicine Product

Table 126. Myriad Genetics Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 127. Myriad Genetics Recent Development

Table 128. Novartis Company Detail

Table 129. Novartis Business Overview

Table 130. Novartis Oncology Precision Medicine Product

Table 131. Novartis Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 132. Novartis Recent Development

Table 133. OPKO Health Company Detail

Table 134. OPKO Health Business Overview

Table 135. OPKO Health Oncology Precision Medicine Product

Table 136. OPKO Health Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 137. OPKO Health Recent Development

Table 138. Pacific Biosciences Company Detail

Table 139. Pacific Biosciences Business Overview

Table 140. Pacific Biosciences Oncology Precision Medicine Product

Table 141. Pacific Biosciences Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 142. Pacific Biosciences Recent Development

Table 143. Quest Diagnostics Company Detail

Table 144. Quest Diagnostics Business Overview

Table 145. Quest Diagnostics Oncology Precision Medicine Product

Table 146. Quest Diagnostics Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 147. Quest Diagnostics Recent Development

Table 148. Qiagen Company Detail

Table 149. Qiagen Business Overview

Table 150. Qiagen Oncology Precision Medicine Product

Table 151. Qiagen Revenue in Oncology Precision Medicine Business (2019-2024) & (US$ Million)

Table 152. Qiagen Recent Development

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oncology Precision Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Oncology Precision Medicine Market Share by Type: 2023 VS 2030

Figure 3. Applied Sciences Features

Figure 4. Precision Diagnostics Features

Figure 5. Digital Health and Information Technology Features

Figure 6. Precision Therapeutics Features

Figure 7. Global Oncology Precision Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Oncology Precision Medicine Market Share by Application: 2023 VS 2030

Figure 9. Breast Cancer Case Studies

Figure 10. Lung Cancer Case Studies

Figure 11. Colorectal Cancer Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Cervical Cancer Case Studies

Figure 14. Other Cancer Case Studies

Figure 15. Oncology Precision Medicine Report Years Considered

Figure 16. Global Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Oncology Precision Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Oncology Precision Medicine Market Share by Region: 2023 VS 2030

Figure 19. Global Oncology Precision Medicine Market Share by Players in 2023

Figure 20. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2023

Figure 22. North America Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Oncology Precision Medicine Market Share by Country (2019-2030)

Figure 24. United States Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Oncology Precision Medicine Market Share by Country (2019-2030)

Figure 28. Germany Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Oncology Precision Medicine Market Share by Region (2019-2030)

Figure 36. China Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Oncology Precision Medicine Market Share by Country (2019-2030)

Figure 44. Mexico Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Oncology Precision Medicine Market Share by Country (2019-2030)

Figure 48. Turkey Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Abbott Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 51. Agilent Technologies Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 52. Almac Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 53. ANGLE plc Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 54. Asuragen Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 55. BGI Group Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 57. BioMérieux Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 58. Bristol Myers Squibb Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 59. Roche Holding AG Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 60. Gilead Sciences Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 61. Illumina Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 62. Konica Minolta Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 63. LabCorp Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 64. MDxHealth Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 65. Myriad Genetics Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 66. Novartis Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 67. OPKO Health Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 68. Pacific Biosciences Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 69. Quest Diagnostics Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 70. Qiagen Revenue Growth Rate in Oncology Precision Medicine Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Precision Medicine Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Oncology Precision Medicine Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-33A5667

Global Oncology Precision Medicine Market Research Report 2024

FEATURED COMPANIES

Oncology Precision Medicine Market Size

Oncology Precision Medicine Market

Report Scope

Scope of Oncology Precision Medicine Market Report

Chapter Outline

FAQ for this report

How fast is Oncology Precision Medicine Market growing?

What is the Oncology Precision Medicine Market size in 2030?

Who are the main players in the Oncology Precision Medicine Market report?

What are the Application segmentation covered in the Oncology Precision Medicine Market report?

What are the Type segmentation covered in the Oncology Precision Medicine Market report?

FEATURED COMPANIES